4//SEC Filing
ENDOCYTE INC 4
Accession 0001179110-17-001596
CIK 0001235007operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 3:48 PM ET
Size
8.5 KB
Accession
0001179110-17-001596
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Parker Katherine
VP of Human Resources
Transactions
- Award
Common Stock
2017-02-02+12,500→ 31,609 total - Award
Stock Option (right to buy)
2017-02-02+25,000→ 25,000 totalExercise: $2.16Exp: 2027-02-02→ Common Stock (25,000 underlying)
Holdings
- 1,200(indirect: By Trust)
Common Stock
- 1,200(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents restricted stock units that will vest and be paid 1/4 annually over a period of 4 years beginning on February 2, 2018, in the form of one share of common stock for each restricted stock unit.
- [F2]Includes 631 and 870 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2016 and December 15, 2016, respectively.
- [F3]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 2, 2018.
Documents
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001235007
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 3:48 PM ET
- Size
- 8.5 KB